Currently, osteoporosis treatment involves the use of either suppressing the osteoclast resorption (e.g., bisphosphonates, calcitonin and estrogen) or promoting new bone formation agents (e.g., parathyroid hormone, fluoride) [2]. The gene discussed is PTH; the disease is osteoporosis.